Evidence map›Paper›PMID 40860825›Full record

ArticleFrontiers in oncology2025

Imaging features of CT and MR in hepatic perivascular epithelioid cell tumor: case series and literature review.

Ning Li, Hui Liu, Jing Chen, Yu Kang, Jing Zhou, Janhua Wang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ning LiDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nan Jing, China.
Hui LiuDepartment of Ultrasonic Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nan Jing, China.
Jing ChenDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nan Jing, China.
Yu KangDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nan Jing, China.
Jing ZhouDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nan Jing, China.
Janhua WangDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nan Jing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To retrospectively analyze the clinical and imaging data of 4 patients with hepatic PEComa of different pathological grades, and to review relevant literature, aiming to enhance clinical awareness of this disease and provide support for preoperative diagnosis. Methods: A retrospective analysis was conducted on 4 cases of patients with hepatic PEComa who were confirmed by surgery and biopsy in our hospital. All patients had complete clinical data, including laboratory tests, abdominal imaging studies, as well as pathological and immunohistochemical examinations. Results: Four cases of hepatic PEComa were identified. All patients were female, aged between 51 and 62 years. The largest diameter of the lesions ranged from 2.4 cm to 20.0 cm. All four lesions presented a round or oval shape with well-defined margins. Three lesions showed homogeneous density/signal, while one lesion displayed heterogeneous density with extensive necrosis. All four cases had a rich blood supply, characterized by significant enhancement in the arterial phase. In two cases, curved and dilated feeding arteries were observed at the periphery of the lesions, and in one case, early visualization of the hepatic vein occurred during the arterial phase. Immunohistochemical staining was positive for HMB45 (+/++), Melan-A (+/++), and SMA (+/++) in all four cases. Conclusion: Hepatic PEComa is a rare tumor with no typical clinical manifestations, and laboratory tests usually show no significant abnormalities. CT and MRI are valuable in preoperative diagnosis. When a lesion exhibits prominent arterial phase enhancement along with thickened and tortuous vessels, and there are no specific findings in the clinical history and laboratory tests, hepatic PEComa should be included in the differential diagnosis.

Indexed as

CThepaticliverMRPEComas

Identifiers

PMID40860825
PMCPMC12375476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.